リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Therapeutic effect of bovine amniotic fluid in murine dry eye model」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Therapeutic effect of bovine amniotic fluid in murine dry eye model

Kulualp, Kadri Kiliç, Servet Eröksüz, Yesari Eröksüz, Hatice Aslan, Abdullah 北海道大学

2020.08

概要

This study investigated the therapeutic effect of bovine amniotic fluid (BAF) in dry eye (DE) model in 60 female BALB/c mice divided equally into 6 groups. Control group (CG) received 5 µL formal saline and experimental groups 0.2% benzalkonium chloride in both eyes twice a day during 14 days. From 15 to 30 days while CG and DE group only was administered saline, other groups called BAF20, BAF35, BAF50 and BAF100 received 5 µL 20, 35, 50 and 100% BAF three times a day, respectively. On day 15, in all experimental groups tear production decreased, tear break-up time shortened, corneal fluorescein staining score increased compared to baseline; on day 30, for these parameters the most effective BAF concentrations were 35%, 50% and 100%. According to western blot analysis the lowest levels were obtained in CG and BAF35 groups for tumor necrosis factorα (TNF-α), vascular endothelial growth factor (VEGF) and cytokeratin 10 (K10); CG for adiponectin receptor-1 (AdipoR1); BAF35 and CG for adiponectin receptor-2 (AdipoR2) (P < 0.05). In the immunohistochemical analysis the lowest levels were in CG, BAF35, BAF50 and BAF100 groups for TNF-α, VEGF and K10; CG, BAF35 and BAF50 groups for AdipoR1; CG, BAF20, BAF35 and BAF50 groups for AdipoR2 (P < 0.05). TUNEL method revealed a lower apoptotic cell score in all BAF groups (P > 0.05). In conclusion; moderate to high concentrations of BAF have the more beneficial effects on DE at molecular and clinical signs and it can be used for the treatment.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

1) Altinors DD, Bozbeyoglu S, Karabay G, Akova YA. Evaluation of ocular surface changes in a rabbit dry eye model using a modified impression cytology technique. Curr Eye Res 32, 301-307, 2007.

2) Aslan A, Gok O, Erman O, Kuloglu T. Ellagic acid impedes carbontetrachloride- induced liver damage in rats through suppression of NF-kB, Bcl-2 and regulating Nrf-2 and caspase pathway. Biomed Pharmacother 105, 662-669, 2018.

3) Aslan A. The effects of different essential fruit juice and their combination on Saccharomyces cerevisiae cell growth. Prog Nutr 17, 36-40, 2015.

4) Barabino S, Dana MR. Animal Models of dry eye: A critical Assessment of Opportunities and Limitations. Invest Ophthalmol Vis Sci 45, 1641-1646, 2004.

5) Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The controlled- environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci 46, 2766- 2771, 2005.

6) Bates N, Edwards N. Benzalkonium chloride exposure in cats: a retrospective analysis of 245 cases reported to the Veterinary Poisons Information Service (VPIS). Vet Rec 176, 229, 2015.

7) Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 41, 1356- 1363, 2000.

8) Burgalassi S, Panichi L, Chetoni P, Saettone MF, Boldrini E. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res 31, 229-235, 1999.

9) Calonge M. The Treatment of Dry Eye. Surv Ophthalmol 45, 227-239, 2001.

10) Chen W, Zhang X, Zhang J, Chen J, Wang S, Wang Q, Qu J. A murine model of dry eye induced by an intelligently controlled environmental system. Invest Ophthalmol Vis Sci 49, 1386-1391, 2008.

11) Choi JH, Kim JH, Li Z, Oh HJ, Ahn KY, Yoon KC. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye. Korean J Ophthalmol 29, 131-137, 2015.

12) Esmaeili A, Abbasian B, Kazemini H, Adibi S. Effect of bovine amniotic fluid on intra- abdominal adhesion in male rats. Int J Surg 8,639-42, 2010.

13) Fabiani C, Barabino S, Rashid S, Dana MR. Corneal epithelial proliferation and thickness in a mouse model of dry eye. Exp Eye Res 89, 166-171, 2009.

14) Foulks GN. Pharmacological management of dry eye in the elderly patient. Drugs Aging 25, 105-118, 2008. 15)Gayton JL. Etiology, prevalance, and treatment of dry eye disease. Clin Ophthalmol 3, 405-412, 2009.

15) Gayton JL. Etiology, prevalance, and treatment of dry eye disease. Clin Ophthalmol 3, 405-412, 2009.

16) Gonenci R, Altug ME, Koc A, Yalcin A. Effects of Bovine Amniotic Fluid on Acute Corneal Alkali Burns in the Rat. J Anim Vet Adv 8, 617-623, 2009.

17) Gumus K, Cavanagh DH. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol 3, 57-67, 2009.

18) Herretes S, Suwan-Apichon O, Pirouzmanesh A, Reyes JM, Broman AT, Cano M, Gehlbach PL, Gurewitsch ED, Duh EJ, Behrens A. Use of topical human amniotic fluid in the treatment of acute ocular alkali injuries in mice. Am J Ophthalmol 142, 271-278, 2006.

19) Kang SW, Kim KA, Lee CH, Yang SJ, Kang TK, Jung JH, Kim TJ, Oh SR, Jung SH. A standardized extract of Rhynchosia volubilis Lour. exerts a protective effect on benzalkonium chloride-induced mouse dry eye model. J Ethnopharmacol 215, 91-100, 2018.

20) Katsiougiannis S, Kapsogeorgou EK, Manoussakis MN, Skopouli FN. Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin. Arthritis Rheum 54, 2295-2299, 2006.

21) Kilic S, Kulualp K. Efficacy of Several Therapeutic Agents in a Murine Model of Dry Eye Syndrome. Comp Med 66, 112-118, 2016.

22) Kilic S, Kulualp K. Tear Production Rate in a Mouse Model of Dry Eye According to the Phenol Red Thread and Endodontic Absorbent Paper Point Tear Tests. Comp Med 66, 112- 118, 2016.

23) Kim KA, Hyun LC, Jung SH, Yang SJ. The leaves of Diospyros kaki exert beneficial effects on a benzalkonium chloride-induced murine dry eye model. Mol Vis 22, 284-293, 2016.

24) Kim YH, Jung JC, Jung SY, Yu S, Lee KW, Park YJ. Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease. Cornea 35, 234-42, 2016.

25) Kulualp K, Kilic S. Evaluation of the effects of different therapeutic agents on experimental dry eye (DE) for the purposes of ocular surface impairment in mice. J Anim Vet Adv 11, 1555– 1563, 2012.

26) Kumar A, Chandra RV, Reddy AA, Reddy BH, Reddy C, Naveen A. Evaluation of clinical, antiinflammatory and antiinfective properties of amniotic membrane used for guided tissue regeneration: A randomized controlled trial. Dent Res J (Isfahan) 12, 127-135, 2015.

27) Kymionis GD, Bouzoukis DI, Diakonis VF, Siganos C. Treatment of chronic dry eye: focus on cyclosporine. Clin Ophthalmol 2, 829-836, 2008.

28) Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685, 1970.

29) Lange RR, Lima L, Montiani-Ferreira F. Measurement of tear production in black- tufted marmosets (Callithrix penicillata) using 3 different methods: modified Schirmer’s I, phenol red thread, and standardized endodontic absorbent paper points. Vet Ophthalmol 15, 376–382, 2012.

30) Lange RR, Lima L, Przydzimirski AC, Montiani-Ferreira F. Reference values for the production of the aqueous fraction of the tear film measured by the standardized endodontic absorbent paper point test in different exotic and laboratory animal species. Vet Ophthalmol 17, 41–45, 2014.

31) Li J, Tan G, Ding X, Wang Y, Wu A, Yang Q, Ye L, Shao Y. A mouse dry eye model induced by topical administration of the air pollutant particulate matter 10. Biomed Pharmacother 96, 524-534, 2017.

32) Li Y, Cui L, Lee HS, Kang YS, Choi W, Yoon KC. Comparison of 0.3% Hypotonic and Isotonic Sodium Hyaluronate Eye Drops in the Treatment of Experimental Dry Eye. Curr Eye Res 42, 1108-1114, 2017.

33) Li Z, Cui L, Yang JM, Lee HS, Choi JS, Woo JM, Lim SK, Yoon KC. The Wound Healing Effects of Adiponectin Eye Drops after Corneal Alkali Burn. Curr Eye Res 41, 1424- 1432, 2016.

34) Li Z, Woo JM, Chung SW, Kwon MY, Choi JS, Oh HJ, Yoon KC. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye. Invest. Ophthalmol Vis Sci 54, 155-162, 2013.

35) Lima L, Lange RR, Turner-Giannico A, Montiani-Ferreira F. Evaluation of standardized endodontic paper point tear test in New Zealand white rabbits and comparison between corneal sensitivity followed tear tests. Vet Ophthalmol 1, 119-124, 2015.

36) Lin Z, Liu X, Zhou T, Wang Y, Bai L, He H, Liu Z. A mouse dry eye model induced by topical administration of benzalkonium chloride. Mol Vis 17, 257-264, 2011.

37) Maitchouk DY, Beuerman RW, Ohta T, Stern M, Varnell RJ. Tear production after unilateral removal of the main lacrimal gland in squirrel monkeys. Arch Ophthalmol 118, 246-252, 2000.

38) McCabe E, Narayanan S. Advancements in anti-inflammatory therapy for dry eye syndrome. Optometry 80, 555-566, 2009.

39) Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int 112, 71-81, 2015.

40) Oriá AP, Oliveira AV, Pinna MH, Martins Filho EF, Estrela-Lima A, Peixoto TC, Silva RM, Santana FO, Meneses ÍD, Requião KG, Ofri R. Ophthalmic diagnostic tests, orbital anatomy, and adnexal histology of the broad-snouted caiman (Caiman latirostris). Vet Ophthalmol 1, 30-39, 2015.

41) Pauly A, Labbe A, Baudouin C, Liang H, Warnet JM, Brignole-Baudouin F. In vivo confocal microscopic grading system for standardized corneal evaluation: application to toxic-induced damage in rat. Curr Eye Res 33, 826-838, 2008.

42) Pauly A, Brignole-Baudouin F, Labbé A, Liang H, Warnet JM, Baudouin C. New tools for the evaluation of toxic ocular surface changes in the rat. Invest Ophthalmol Vis Sci 48, 5473- 5483, 2007.

43) Pinto-Fraga J, López-de la Rosa A, Blázquez Arauzo F, Urbano Rodríguez R, González- García MJ. Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease. Eye Contact Lens 43, 57-63, 2016.

44) Quinto GG, Camacho W, Castro-Combs J, Li L, Martins SA, Wittmann P, Campos M, Behrens A. Effects of topical human amniotic fluid and human serum in a mouse model of keratoconjunctivitis sicca. Cornea 31, 424-430, 2012.

45) Quinto GG, Castro-Combs J, Li L, Gupta N, Campos M, Behrens A. Outcomes of different concentrations of human amniotic fluid in a keratoconjunctivitis sicca-induced mouse model. Int Ophthalmol 36, 643-650, 2016.

46) Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2, 203-210, 2001.

47) Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E. The challenge of dry eye diagnosis. Clin Ophthalmol 2, 31-55, 2008.

48) She Y, Li J, Xiao B, Lu H, Liu H, Simmons PA, Vehige JG, Chen W. Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model. J Ocul Pharmacol Ther 31, 525-30, 2015.

49) Skalicky SE, Petsoglou C, Gurbaxani A, Fraser CL, McCluskey P. New agents for treating dry eye syndrome. Curr Allergy Asthma Rep 13, 322-328, 2013.

50) Sullivan DA, Allansmith MR. Hormonal modulation of tear volume in the rat. Exp Eye Res 42, 131-139, 1986.

51) Sung MS, Li Z, Cui L, Choi JS, Choi W, Park MJ, Park SH, Yoon KC. Effect of Topical 5-Aminoimidazole-4-carboxamide-1- β -d-Ribofuranoside in a Mouse Model of Experimental Dry Eye. Invest Ophthalmol Vis Sci 56, 3149-3158, 2015.

52) Tavares Fde P, Fernandes RS, Bernardes TF, Bonfioli AA, Soares EJ. Dry eye disease. Semin Ophthalmol 25, 84-93,2010.

53) Urzua CA, Vasquez DH, Huidobro A, Hernandez H, Alfaro J. Randomized double- blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. Curr Eye Res 37, 684-888, 2012.

54) Xiao X, He H, Lin Z, Luo P, He H, Zhou T, Zhou Y, Liu Z. Therapeutic effects of epidermal growth factor on benzalkonium chloride- induced dry eye in a mouse model. Invest Ophthalmol Vis Sci 53, 191-197, 2012.

55) Xiao X, Luo P, Zhao H, Chen J, He H, Xu Y, Lin Z, Zhou Y, Xu J, Liu Z. Amniotic membrane extract ameliorates benzalkonium chloride- induced dry eye in a murine model. Exp Eye Res 115, 31-40, 2013.

56) Xiong C, Chen D, Liu J, Liu B, Li N, Zhou Y, Liang X, Ma P, Ye C, Ge J, Wang Z. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci 49, 1850-1856, 2008.

57) Yagci A, Gurdal C. The role and treatment of inflammation in dry eye disease. Int Ophthalmol 34, 1291-1301, 2014.

58) Yang QC, Bao J, Li C, Tan G, Wu AH, Ye L, Ye LH, Zhou Q, Shao Y. A murine model of dry eye induced by topical administration of erlotinib eye drops. Int J Mol Med 41, 1427-1436, 2018.

59) Zhang Z, Yang WZ, Zhu ZZ, Hu QQ, Chen YF, He H, Chen YX, Liu ZG. Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model. Invest Ophthalmol Vis Sci 55, 2963-2974, 2014.

60) Zhu L, Shen J, Zhang C, Park CY, Kohanim S, Yew M, Parker JS, Chuck RS. Inflammatory cytokine expression on the ocular surface in the Botulinum toxin B induced murine dry eye model. Mol Vis 15, 250-258, 2009.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る